Federal
Register Notices > Notice
of Registration - 2005 > Siegfried (USA), Inc.
FR Doc 05-14835 [Federal Register: July 27, 2005 (Volume 70, Number
143)] [Notices] [Page 43457] From the Federal Register Online via GPO
Access [wais.access.gpo.gov] [DOCID:fr27jy05-125]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated February 23, 2005, and published in the Federal
Register on March 4, 2005, (70 FR 10683), Siegfried (USA), Inc.,
Industrial Park Road, Pennsville, New Jersey 08070, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic class of controlled
substances listed in Schedule II:
Drug |
Schedule |
Amphetamine (1100) |
II |
Methylphenidate (1724) |
II |
Amobarbital (2125) |
II |
Pentobarbital (2270) |
II |
Secobarbital (2315) |
II |
Glutethimide (2550) |
II |
Codeine (9050) |
II |
Hydrocodone (9193) |
II |
Methadone (9250) |
II |
Methadone Intermediate (9254) |
II |
Dextropropoxyphene, bulk (non-dosage form)
(9273) |
II |
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21
U.S.C. 823(a) and determined that the registration
of Siegfried (USA), Inc. to manufacture the listed basic class of
controlled substances is consistent with the public interest at this
time. DEA has investigated Siegfried (USA), Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background
and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance
with 21 CFR
1301.33, the above named company is granted registration
as a bulk manufacturer of the basic class of controlled substances
listed.
Dated: July 19, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-14835 Filed 7-26-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|